Don
Children's Guaifenesin Grape Liquid and Guaifenesin DM Cherry Liquid by Perrigo Company: Recall - Potential Defect with Dosage Cup
Including store brands:
- Sunmark
- Rite-Aid
- Topcare
- Kroger
- GoodSense
- Dollar General
- Care One
- CVS
[Posted 01/13/2016]
AUDIENCE: Consumer
ISSUE: Perrigo Company announced that, following the recent recall of certain dosing cups by its supplier, it has initiated a voluntary product recall in the US to the retail level of 2 batches of its children's guaifenesin grape liquid (100mg/5 mL) and 3 batches of its children's guaifenesin DM cherry liquid (100mg guaifenesin and 5mg dextromethorphan HBr/ 5 ml) sold in 4 oz. bottles with dosage cup in a box under multiple store brand product names. Some packages contain an oral dosing cup with incorrect dose markings. See the press release for affected label and lot numbers.
At risk populations such as those who are poor metabolizers of dextromethorphan may experience an overdose by a factor of 3, if incorrect measuring levels are used.
Consumers should be aware that an overdose of Guaifenesin DM may cause hyper excitability, rapid eye movements, changes in muscle reflexes, ataxia, dystonia, hallucinations, stupor, and coma. Other effects have included nausea, vomiting, tachycardia, irregular heartbeat, seizures, respiratory depression, and death. Small children who are poor metabolizers of dextromethorphan and use the product regularly over a period of several days at the mistaken dose, may develop cumulative toxicity. Moreover, adverse reactions to guaifenesin when given in high or excessive dosage may include nausea/vomiting, diarrhea, and/or abdominal pain. Therefore, an extreme overdose in an at risk population may need medical intervention, but in most cases adverse health consequences are temporary and reversible.
BACKGROUND: These recalled products are sold by distributors nationwide and distributed through retail stores.
RECOMMENDATION: Gastric decontamination is recommended after acute ingestion of greater than 10 mg/kg, if administered soon after ingestion.
Consumers that have product with the corresponding labels and batch numbers listed in the Press Release should discard the dosing device and product and may call Perrigo, toll free, Monday through Friday from 8:00 AM to 10:00 PM EST, at 1-888-345-0479, or visit mucusreliefrecall.com. Consumers should contact their physician or healthcare provider if they have any questions, or if they or their children experience any problem that could possibly be related to this drug product.
Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:
- Complete and submit the report Online: www.fda.gov/MedWatch/report
- Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
[01/11/2016 - Press Release - Perrigo]
Page Last Updated: 01/13/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm481563.htm
Medical - MedWatch and FDA.gov Safety Information and Adverse Event Reporting Programs
- Stay Informed > FDA MedWatch Text Messaging Pilot
- Information by Drug Class > Acetaminophen Information
- Consumer Updates > FDA's MedWatch Safety Alerts: August 2010
- MedWatch Home Page
- List of Medical Device Recalls > Mizuho OSI Modular Table Systems
- Press Announcements > FDA approves Farxiga to treat type 2 diabetes
- Download Forms
- Safety Alerts for Human Medical Products > 2010 Safety Alerts for Human Medical Products
- Safety Alerts for Human Medical Products > Fingerstick Devices to Obtain Blood Specimens: Initial Communication - Risk of Transmitting Bloodborne Pathogens
- Safety Alerts for Human Medical Products > Huber Needles: Recall - Risk of Coring
- Safety Alerts for Human Medical Products > Actos (pioglitazone): Ongoing Safety Review - Potential Increased Risk of Bladder Cancer
- Safety Alerts for Human Medical Products > Avandia (rosiglitazone): REMS - Risk of Cardiovascular Events
- Safety Alerts for Human Medical Products > Chelation Products: Unapproved Over-the-Counter Drugs - Consumer Warning
- Safety Alerts for Human Medical Products > Excelsior Medical 5 ml Fill in 6 cc Prefilled Saline Flush Syringes: Recall - Potential Loss of Sterility
- Safety Alerts for Human Medical Products > Reese Pharmaceutical Company OTC Products: Recall - Mislabeled Guaifenesin Tablets
- Safety Alerts for Human Medical Products > Rolaids Extra Strength Softchews, Rolaids Extra Strength plus Gas Softchews, Rolaids Multi-Symptom plus Anti-Gas Softchews: Recall - Foreign Materials in Products
- Safety Alerts for Human Medical Products > Fruta Planta: Public Notification - Undeclared Drug Ingredient
- Safety Alerts for Human Medical Products > Rock Hard Extreme and Passion Coffee by Drive Total Energy: Recall - Undeclared Drug Ingredient
- Safety Alerts for Human Medical Products > Triad Alcohol Prep Pads, Alcohol Swabs, and Alcohol Swabsticks: Recall Due to Potential Microbial Contamination
- Safety Alerts for Human Medical Products > Acetaminophen Prescription Products Limited to 325 mg Per Dosage Unit: Drug Safety Communication
- Safety Alerts for Human Medical Products > American Regent Injectable Products: Recall - Visible Particulates in Products
- Safety Alerts for Human Medical Products > Hydrocodone Bitartrate And Acetaminophen Tablets, Phenobarbital Tablets by Qualitest: Recall - Incorrect Package Labeling
- Safety Alerts for Human Medical Products > Warfarin Sodium Tablets (Jantoven), 3mg: Recall - Mislabeled Bottles Containing Higher Dosage
- Safety Alerts for Human Medical Products > Unapproved Cough, Cold, Allergy Products: FDA Prompts Removal From Market
- Safety Alerts for Human Medical Products > Topamax (topiramate): Label Change - Risk For Development of Cleft Lip and/or Cleft Palate in Newborns
- Safety Alerts for Human Medical Products > Black Ant: Undeclared Drug Ingredient
- Safety Alerts for Human Medical Products > H & P Industries Povidine Iodine Prep Pads: Recall - Potential Microbial Contamination
- Safety Alerts for Human Medical Products > U-Prosta: Undeclared Drug Ingredient
- Safety Alerts for Human Medical Products > Soladek Vitamin Solution: Unapproved Product May Contain Dangerously High Levels of Vitamins A and D
- Safety Alerts for Human Medical Products > Best Enhancer: Recall – Undeclared Drug Ingredient
- Safety Alerts for Human Medical Products > Topamax (topiramate): Recall - Musty Odor
- Safety Alerts for Human Medical Products > Lansoprazole Delayed-Release Orally Disintegrating Tablets by Teva Pharmaceuticals: Letter to Healthcare Professionals - Clogged, Blocked Oral Syringes and Feeding Tubes
- Safety Alerts for Human Medical Products > Regenerect: Recall - Undeclared Drug Ingredient
- Safety Alerts for Human Medical Products > Coumadin (warfarin sodium) Crystalline 5 mg Tablets: Recall - Tablets May Have Higher than Expected Potency
- Safety Alerts for Human Medical Products > Defibtech Lifeline and ReviveR Automated External Defibrillators (AEDs): Recall - Software Defect May Cancel Shock
- Safety Alerts for Human Medical Products > Birth Control Pills Containing Drospirenone: Possible Increased Risk of Blood Clots
- Safety Alerts for Human Medical Products > Thermographic Imaging Systems for Breast Cancer Screening: FDA Safety Communication
- Safety Alerts for Human Medical Products > Zocor (simvastatin): Label Change - New Restrictions, Contraindications, and Dose Limitations
- Victoza (liraglutide [rDNA origin]) Injection: REMS - Risk of Thyroid C-cell Tumors, Acute Pancreatitis
- Safety Alerts for Human Medical Products > Boston Scientific Innova Self-Expanding Stent System: Recall - Failure to Deploy
- Safety Alerts for Human Medical Products > Tylenol Extra Strength Caplets, 225 count bottles: Recall - Uncharacteristic Odor
- Safety Alerts for Human Medical Products > Tamiflu (oseltamivir phosphate) for Oral Suspension: Label Change-New Concentration (6 mg/mL)
- Safety Alerts for Human Medical Products > CardioGen-82 PET Scan: Drug Safety Communication - Increased Radiation Exposure
- Safety Alerts for Human Medical Products > Multaq (dronedarone): Drug Safety Communication - Increased Risk of Death or Serious Cardiovascular Events
- Safety Alerts for Human Medical Products > Silencer S2200 Centrifuge by Global Focus Marketing & Distribution, Ltd.: Class I Recall - Biohazardous Materials May be Released
- CooperVision Avaira Toric Soft Contact Lenses: Class 1 Recall- Unintended Residue on Lenses
- Safety Alerts for Human Medical Products > Nostrilla Nasal Decongestant: Recall - Bacterial Contamination
- Safety Alerts for Human Medical Products > Mizuho OSI Modular Table Systems: Class I Recall - Reports of Patient Injury
- Safety Alerts for Human Medical Products > Gilenya (fingolimod): Drug Safety Communication - Safety Review of a Reported Death After the First Dose
- Safety Alerts for Human Medical Products > ShoulderFlex Massager: Warning - Risk of Strangulation
- Safety Alerts for Human Medical Products > Eclectic Institute Dietary Supplements: Recall - Possible Salmonella Contamination
- Safety Alerts for Human Medical Products > Liquid Acetaminophen marketed for infants: Drug Safety Communication - Potential for Dosing Errors
- Safety Alerts for Human Medical Products > Novartis Consumer Health Over-The-Counter Products: Recall - Potential Presence of Foreign Tablets or Chipped or Broken Tablets or Gelcaps
- Safety Alerts for Human Medical Products > Adcetris (brentuximab vedotin): Drug Safety Communication - Progressive Multifocal Leukoencephalopathy and Pulmonary Toxicity
- Safety Alerts for Human Medical Products > Victrelis (boceprevir) and Ritonavir-Boosted Human Immunodeficiency Virus (HIV) Protease Inhibitor Drugs: Drug Safety Communication - Drug Interactions
- Safety Alerts for Human Medical Products > Hand-held Dental X-Ray Units: FDA Safety Communication - Unreviewed Products May Not Be Safe or Effective
- Safety Alerts for Human Medical Products > IV Solutions from Wallcur of San Diego: CDER Statement - FDA Warns Health Care Professionals Not to Inject Patients
- Safety Alerts for Human Medical Products > Endoscopic Retrograde Cholangiopancreatography (ERCP) Duodenoscopes: FDA Safety Communication - Design May Impede Effective Cleaning
- Safety Alerts for Human Medical Products > Testosterone Products: Drug Safety Communication - FDA Cautions About Using Testosterone Products for Low Testosterone Due to Aging; Requires Labeling Change to Inform of Possible Increased Risk of Heart Attack And Stroke
- Safety Alerts for Human Medical Products > Over-the-Counter Asthma Products Labeled as Homeopathic: FDA Statement - Consumer Warning About Potential Health Risks
- Safety Alerts for Human Medical Products > Zyprexa Relprevv (olanzapine pamoate): Drug Safety Communication - FDA Review of Study Sheds Light on Two Deaths Associated with the Injectable Schizophrenia Drug
- Safety Alerts for Human Medical Products > Hepatitis C Treatments Containing Sofosbuvir in Combination With Another Direct Acting Antiviral Drug: Drug Safety Communication - Serious Slowing of Heart Rate When Used With Antiarrhythmic Drug Amiodarone
- Safety Alerts for Human Medical Products > Mammograms at Richard D. Adelman M.D. in Raleigh, North Carolina: FDA Safety Communication - Quality Problems
- Safety Alerts for Human Medical Products > Duodenoscope Model TJF-Q180V by Olympus: FDA Safety Communication - New Reprocessing Instructions Validated
- Safety Alerts for Human Medical Products > Feraheme (ferumoxytol): Drug Safety Communication – Warnings Strengthened and Prescribing Instructions Changed
- Safety Alerts for Human Medical Products > Products from Prescription Center Pharmacy in Fayetteville, N.C.: Recall - Lack of Sterility Assurance
- Safety Alerts for Human Medical Products > Flurbiprofen-Containing Topical Pain Medications: FDA Alert - Illnesses and Deaths in Pets Exposed to Prescription Topical Pain Medication
- Safety Alerts for Human Medical Products > Injectable Products by Mylan: Recall - Presence of Particulate Matter
- Safety Alerts for Human Medical Products > SGLT2 inhibitors: Drug Safety Communication - FDA Warns Medicines May Result in a Serious Condition of Too Much Acid in the Blood
- Safety Alerts for Human Medical Products > M/L Taper with Kinectiv Technology Prosthesis by Zimmer: Class I Recall - Higher than Expected Levels of Manufacturing Residues
- Safety Alerts for Human Medical Products > Covidien Shiley Neonatal and Pediatric Tracheostomy Tubes by Medtronic: Recall - Tubes Formed With Wider-angle Bend Than Standard Models
- Safety Alerts for Human Medical Products > Daytrana Patch (methylphenidate transdermal system): Drug Safety Communication - Permanent Skin Color Changes
- Safety Alerts for Human Medical Products > Codeine Cough-and-Cold Medicines in Children: Drug Safety Communication - FDA Evaluating Potential Risk of Serious Side Effects
- Safety Alerts for Human Medical Products > Unapproved Prescription Ear Drop (Otic) Products: Not FDA Evaluated for Safety, Effectiveness and Quality
- Safety Alerts for Human Medical Products > Lifesaver Single Patient Use Manual Resuscitator by Teleflex Hudson RCI: Class I Recall - Intake Port Blockage
- Safety Alerts for Human Medical Products > Non-aspirin Nonsteroidal Anti-inflammatory Drugs (NSAIDs): Drug Safety Communication - FDA Strengthens Warning of Increased Chance of Heart Attack or Stroke
- Safety Alerts for Human Medical Products > Gilenya (fingolimod): Drug Safety Communication - FDA Warns About Cases of Rare Brain Infection
- Safety Alerts for Human Medical Products > Compounded or Repackaged Drugs Stored in Becton-Dickinson Syringes: FDA Expands Warning
- Safety Alerts for Human Medical Products > Clozapine: Drug Safety Communication - FDA Modifies Monitoring for Neutropenia; Approves New Shared REMS Program
- Safety Alerts for Human Medical Products > Ayurvedic Dietary Supplements by Shree Baidyanath: Consumer Advice Notice - Products Contain High Levels of Lead and/or Mercury
- Safety Alerts for Human Medical Products > Acetaminophen Tablets by Medline Industries: Recall - Mislabeling with Incorrect Strength
- Safety Alerts for Human Medical Products > Heater-Cooler Devices: FDA Safety Communication - Use of Devices Associated With Nontuberculous Mycobacteria Infections
- Safety Alerts for Human Medical Products > Heater-Cooler Devices: FDA Safety Communication - Use of Devices Associated With Nontuberculous Mycobacteria Infections
- Safety Alerts for Human Medical Products > Plavix (clopidogrel): Drug Safety Communication - Long-term Treatment Does Not Change Risk of Death
- Safety Alerts for Human Medical Products > G5 Ventilator by Hamilton: Class I Recall - Ventilation and Alarm Failure
- Safety Alerts for Human Medical Products > Endoscope Washer/Disinfectors by Custom Ultrasonics: Safety Communication - FDA Recommends Health Care Facilities Transition to Alternate Reprocessing Methods
- Safety Alerts for Human Medical Products > Compounded Multivitamins by Glades Drugs: Voluntary Recall - High Amounts of Vitamin D3 (Cholecalciferol)
- Safety Alerts for Human Medical Products > OmniPod Insulin Management System by Insulet: Field Safety Notification - Reported Cases of Needle Mechanism Deployment Failure or Delay
- Safety Alerts for Human Medical Products > SGLT2 Inhibitors: Drug Safety Communication - Labels to Include Warnings About Too Much Acid in the Blood and Serious Urinary Tract Infections
- Safety Alerts for Human Medical Products > Lipo Escultura: Recall - Undeclared Drug Ingredients
- Safety Alerts for Human Medical Products > Chariot Guiding Sheath by Boston Scientific: Recall - Risk of Shaft Separation
- Safety Alerts for Human Medical Products > Rosiglitazone-containing Diabetes Medicines: Drug Safety Communication - FDA Eliminates the Risk Evaluation and Mitigation Strategy (REMS)
- Safety Alerts for Human Medical Products > Children's Guaifenesin Grape Liquid and Guaifenesin DM Cherry Liquid by Perrigo Company: Recall - Potential Defect with Dosage Cup
- Safety Information > Zestril (lisinopril) tablets
- Safety Information > Zestoretic (lisinopril and hydrochlorothiazide) and Zestril (lisinopril) tablets
- Safety Information > Norvasc (amlodipine besylate) tablets
- Safety Information > October 2011
- MedWatch: The FDA Safety Information and Adverse Event Reporting Program
- MedWatch The FDA Safety Information and Adverse Event Reporting Program > MedWatch Widget
- Recalls, Market Withdrawals, & Safety Alerts > Ortho-McNeil Neurologics Voluntarily Recalls Two Lots of TOPAMAX®
- Recalls, Market Withdrawals, & Safety Alerts > Quaker Oats Issues Voluntary Recall Of Specific 8-Count Quaker Chewy Smashbar Graham Pretzel Snack Bars Due To Undeclared Milk Allergen
- Recalls, Market Withdrawals, & Safety Alerts > Best Food Cash & Carry Issues Allergy Alert On Undeclared Sulfite In Deer Brand “Raisin Golden�
- FDA Expands Its Warning about the Risk of Botulism Poisoning From Certain Castleberry's Food Products and Dog Food
- MedWatch Home Page
- MedWatch The FDA Safety Information and Adverse Event Reporting Program > MedWatch Widget
- Safety Alerts for Human Medical Products > 2010 Safety Alerts for Human Medical Products
- Safety Alerts for Human Medical Products > Heater-Cooler Devices: FDA Safety Communication - Use of Devices Associated With Nontuberculous Mycobacteria Infections
- Safety Information > Zestoretic (lisinopril and hydrochlorothiazide) and Zestril (lisinopril) tablets
- Safety Information > Zestril (lisinopril) tablets
- Search Results: lisinopril
- Stay Informed > FDA MedWatch Text Messaging Pilot
- Safety Alerts for Human Medical Products > Rosiglitazone-containing Diabetes Medicines: Drug Safety Communication - FDA Eliminates the Risk Evaluation and Mitigation Strategy (REMS)
- Fighting Skin Cancer: FDA Acts to Ban Tanning Beds for Minors
- Safety Alerts for Human Medical Products > Children's Guaifenesin Grape Liquid and Guaifenesin DM Cherry Liquid by Perrigo Company: Recall - Potential Defect with Dosage Cup
Webmd.com Articles
- 10 Best Low-Carb Snacks
- 1 in 5 Americans Had H1N1 Swine Flu
- Bipolar Disorder Supplements
- Build Stronger Bones With Exercise: Walking, Stretching, Strength Training, and More
- Build Stronger Bones With Nutrition: Calcium, Vitamin D, and More
- Calcium Scan Can Predict Premature Death Risk, Study Says – WebMD
- Children with Autism Respond Differently to Smells: Study – WebMD
- Christina Applegate's Double Mastectomy: FAQ
- Chronic Ills May Add Up to a Shortened Life Span – WebMD
- Disability Gender Gap for Seniors
- Do Cholesterol Drugs Affect Aggression? – WebMD
- drug-145704-Januvia+Oral.aspx
- Drugs and Treatments - Detrol LA Oral - Patient Handout from WebMD
- Drugs and Treatments - Flomax Oral - Patient Handout from WebMD
- Drug Tests Often Trigger False Positives
- EPA: Greenhouse Gasses Are Health Threat
- FAQ: Heartburn Meds and Health Risks
- FDA Strengthens Warning on NSAIDs and Heart Risk
- FDA Strengthens Warning on NSAIDs and Heart Risk
- Glucose Meter - Type 2 Diabetes Support Group at WebMD
- H1N1 Swine Flu Deadly in All Age Groups
- Hydrochlorothiazide Oral : Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD
- Januvia, Janumet to Note Pancreatitis Cases
- Losing Love Has Similarities to Addiction
- Masturbation and Prostate Cancer Risk
- Metformin Linked to B12 Deficiency
- Metformin vs. Sulfonylureas for Diabetes
- Migraine's Link to Higher Heart Disease Risk May Not Be Genetic – WebMD
- Mind Reading Not Just Science Fiction?
- Miranda Hitti
- Most U.S. Hepatitis C Infections May Be Missed: Study – WebMD
- Multiple Sclerosis Pictures: MS Brain Lesions, Symptoms, Causes, Types, and Treatments
- Multiple Sclerosis: Planning for Your Future
- Overweight Older People Live Longer
- Peanut Product Salmonella Outbreak Goes On
- Recall of Defective Glucose Test Strips
- Reduce Your Risk of Nerve Pain and Damage From Diabetes
- Regular Mammograms Might Lead to 'Overdiagnosis' of Breast Cancer – WebMD
- Reye Syndrome - Aspirin or aspirin products should not be given to anyone younger than 20, unless they are specifically prescribed by a doctor.
- Slideshow 12 Diet Mistakes That Prevent Weight Loss
- Southern States Are the Happiest
- Stroke Tied to Long-Term Mental Decline – WebMD
- Study Linking Autism to Vaccine Retracted
- Sugar Health Effects: Is Refined Sugar Bad For You?
- Sugar Shockers: Foods Surprisingly High in Sugar
- Sun Exposure, Vitamin D May Lower MS Risk
- Swine Flu Cases Rising in U.S., World
- Swine Flu Less Severe for Over-50s?
- Swine Flu: U.S. Declares Public Health Emergency
- Tiny Brain Lesions Linked to Raised Risk of Stroke Death – WebMD
- Type 2 Diabetes Diet and Nutrition Tips: Healthy Eating and Exercise -- Interview With Hope Warshaw, MMSc, RD
- U.K. Nurse With Ebola Critically Ill Again
- U.K. Nurse With Ebola Critically Ill Again
- Umbilical Cord Blood May One Day Treat Eczema, RA
- Understanding Epilepsy and Seizures - WebMD
- Very Low Blood Sugar Linked to Dementia
- Vitamins D and E May Affect Dementia Risk
- 'Watchful Waiting' Becoming More Common for Prostate Cancer Patients – WebMD
- WebMD Health Search
- What Isn't Your Loved One Telling You About MS?
- WHO: World Closer to Swine Flu Pandemic
- Wireless Sensor Monitors Heart Failure Patients
- Yuck! What's Really in Your Pool?
- Zika Virus: What You Should Know
- Eating This Daily May Decrease Glaucoma Risk
No comments:
Post a Comment